Important information from the Federal Office for Safety in Health Care concerning the suspension of the marketing authorization and the recall of all batches of the veterinary medicinal product "Kexxtone 32.4 g continuous-release intraruminal device for cattle. Monensin"

Recall due to possible lack of efficacy and unintentional ingestion in non-target species

Recall due to possible non-sterility

Recall due to deviations from the specified values regarding appearance and pH value

With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.

Recall due to deviations from the manufacturing protocol

Recall due to deviations from the specified values regarding appearance and pH value

Recall due to temperature exceedance during transport

Recall due to an undercutting of the pH value and formation of a precipitate

Recall due to possible reduced active ingredient content